BBO-10203

· BridgeBio Oncology Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BBO-10203, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors [Phase 1]